Skip to main content

Table 2 Incidence of adverse outcomes in ACS patients according to the NLR tertiles

From: Predictive efficacy of neutrophil-to-lymphocyte ratio for long-term prognosis in new onset acute coronary syndrome: a retrospective cohort study

  1st tertile ≤ 3.37 (n = 245) 2nd tertile 3.38–6.93 (n = 245) 3rd tertile ≥ 6.94 (n = 247) χ2 P
ACM, n (%) 5 (2.0) 12 (4.9) 7 (2.8) 3.385 0.184
Non-sudden cardiac death, n (%) 1 (0.4) 0 (0.0) 0 (0.0) 1.825 0.665
MACE, n (%) 21 (8.6) 24 (9.8) 20 (8.1) 0.469 0.791
 CM, n (%) 4 (1.6) 12 (4.9) 7 (2.8) 4.421 0.110
 Re-myocardial infarction, n (%) 4 (1.6) 0 (0.0) 2 (0.8) 5.578 0.061
 ST, n (%) 0 (0.0) 0 (0.0) 2 (0.8) 2.617 0.332
 Revascularization, n (%) 11 (4.5) 17 (6.9) 12 (4.9) 1.666 0.435
 Stroke, n (%) 1 (0.4) 0 (0.0) 2 (0.8) 2.764 0.251
Bleeding events, n (%) 1 (0.4) 6 (2.4) 1 (0.4) 5.904 0.052